HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiatherosclerotic effect of dehydrocorydaline on ApoE-/- mice: inhibition of macrophage inflammation.

Abstract
Despite improvements in cardiovascular disease (CVD) outcomes by cholesterol-lowering statin therapy, the high rate of CVD is still a great concern worldwide. Dehydrocorydaline (DHC) is an alkaloidal compound isolated from the traditional Chinese herb Corydalis yanhusuo. Emerging evidence shows that DHC has anti-inflammatory and antithrombotic benefits, but whether DHC exerts any antiatherosclerotic effects remains unclear. Our study revealed that intraperitoneal (i.p.) injection of DHC in apolipoprotein E-deficient (ApoE-/-) mice not only inhibited atherosclerosis development but also improved aortic compliance and increased plaque stability. In addition, DHC attenuated systemic and vascular inflammation in ApoE-/- mice. As macrophage inflammation plays an essential role in the pathogenesis of atherosclerosis, we next examined the direct effects of DHC on bone marrow-derived macrophages (BMDMs) in vitro. Our RNA-seq data revealed that DHC dramatically decreased the levels of proinflammatory gene clusters. We verified that DHC significantly downregulated proinflammatory interleukin (IL)-1β and IL-18 mRNA levels in a time- and concentration-dependent manner. Furthermore, DHC decreased lipopolysaccharide (LPS)-induced inflammation in BMDMs, as evidenced by the reduced protein levels of CD80, iNOS, NLRP3, IL-1β, and IL-18. Importantly, DHC attenuated LPS-induced activation of p65 and the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway. Thus, we conclude that DHC ameliorates atherosclerosis in ApoE-/- mice by inhibiting inflammation, likely by targeting macrophage p65- and ERK1/2-mediated pathways.
AuthorsBin Wen, Yuan-Ye Dang, Su-Hua Wu, Yi-Min Huang, Kong-Yang Ma, Yi-Ming Xu, Xi-Long Zheng, Xiao-Yan Dai
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 43 Issue 6 Pg. 1408-1418 (Jun 2022) ISSN: 1745-7254 [Electronic] United States
PMID34552216 (Publication Type: Journal Article)
Copyright© 2021. The Author(s).
Chemical References
  • Alkaloids
  • Apolipoproteins E
  • Interleukin-18
  • Lipopolysaccharides
  • dehydrocorydalin
Topics
  • Alkaloids
  • Animals
  • Apolipoproteins E
  • Atherosclerosis (metabolism)
  • Inflammation (metabolism)
  • Interleukin-18 (metabolism)
  • Lipopolysaccharides
  • Macrophages (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: